Related by context. All words. (Click for frequent words.) 75 CFR § #.# [006] 75 CFR § #.# [007] 74 CFR § #.# [004] 72 CFR #.# [007] 72 CFR § #.# [002] 72 CFR #.# [005] 71 CFR #.# c 71 CFR § #.# [008] 71 #.#-# [005] 70 CFR § #.# [005] 70 USC § #u 70 #.#-# b [001] 69 CFR § #.# [001] 69 USC § #c 69 Income Tax Regs 69 CFR § #.# [003] 69 CFR #.# d 69 USC § #a [002] 68 CFR § § #.# [002] 68 TCA § #-#-# [003] 68 CFR § § 68 RC #.# B [001] 68 CFR #.# [006] 68 USC § #a [001] 68 CFR § 68 CFR § § #.# [001] 68 § #-#-# b [003] 68 Repl. 67 CFR #.# b 67 #.#-# b [002] 67 cmt 67 USC § #a c 67 § #.#-# [004] 67 FAR #.# 66 USC #a [001] 66 Legal #.# 66 § #a [002] 66 § #.# [004] 66 Pa.CS § 66 USC § #a b 66 § #-#-# b [001] 66 NJAC #:#-#.# 65 USC § #f 65 DC Code § 65 See id 65 MR Civ 65 § #E 65 Colo. Sess 65 § #-#.# [001] 65 CFR #.# [008] 65 § #.# [002] 65 Pa.RAP 65 NCGS § #A 65 § #A [001] 65 Rev. Proc 65 END FOOTNOTE FOOTNOTE 65 END FOOTNOTE * 65 Tenn. R. Civ 65 USCA § 65 CFR #.#b 65 USC § #a [003] 65 NCGS § 64 #.#-# [020] 64 HRS § #-# [001] 64 § #.#.# [001] 64 § #:# [001] 64 NJSA #:#-# [004] 64 IRC § § 64 § #-#-# [004] 64 § #-#-# [003] 64 OCGA § #-#-#.# 64 Section #.#.# [001] 64 KRS #.#-# 64 See ARS § 64 CFR § #.#b 64 R. #:#-# 64 La.Code Crim.P. art 64 #.# 5T 64 Supp. 64 Ark. R. Civ 64 § #-#-# [001] 64 Pa. Code § 64 Pa.CSA § 63 § #-#-# [005] 63 NJSA 2A #A 63 Okla. Stat 63 USCS § 63 LSA CCP art 63 MRS § 63 OCGA § #-#-# [004] 63 NJSA #A :# 63 Ark. Sup 63 Minn. R. Civ 63 Fed.R.Civ.P. 63 § #-#-# [006] 63 § #-#-# [007] 63 #.# subd [004] 63 CFR Parts 63 § #-#-#.# 63 § #.#.# [002] 63 Section #-#-# [005] 63 § #.#-# [007] 63 :9 63 USC § #e 63 #A.# [005] 63 Bankruptcy Code § 62 Subsection b 62 KSA #-# [001] 62 NJAC 6A 62 Docket Entry No. 62 Vernon Supp 62 See Restatement Second 62 § #-#.# [003] 62 § #.# [005] 62 Va. Code § 62 § #-#-# [002] 62 Tex. Admin 62 See USSG § #B#.# 62 ORS #B.# 62 CFR #.# [001] 62 § #.# [001] 62 NJSA 2C :2 62 Hr'g Tr 62 § #c 61 USC § #b [002] 61 CSR #-#.# 61 CFR pt 61 #CFR 61 #d# [001] 61 PS § 61 § #A.# 61 FFDCA 61 Minn. R. Crim 61 § § #-#-# [001] 61 Colorado Revised Statutes 61 #.#-# [006] 61 NASD Marketplace Rule 61 NYCRR #.# [001] 61 USC § #A 61 ARS § 61 Idaho Code § 61 USC § #d 61 SEC Regulation SX 61 #g# 2 61 Section #.# [001] 61 FERC Stats 61 La. Code Civ 61 NJSA #:#-#.# [001] 61 USC § #b [001] 61 § #-#.# [002] 61 § § #.# [002] 61 § #.# [006] 61 RCW #.#A.# 61 § #-#.# [004] 60 IRC § 60 NJSA 2C :5 60 OCGA § #-#-# [005] 60 VSA § 60 § #.# b 60 NASD Rule 60 Subsection c 60 GLc 60 La. RS #:# [001] 60 section #-#-# [001] 60 Id. § 60 Maj. Op 60 NJSA #:#-# [001] 60 Sentencing Guidelines Manual 60 Prof. Code § 60 USC #d 60 section #AA 60 MCL #.# [002] 60 NJSA #:# [001] 60 App'x 60 Subparagraph 60 USC § #t 60 Rev. Rul 60 Compl 60 NYCRR #.# [002] 60 § #-#-# [008] 60 b Vernon Supp 60 OCGA § #-#-# [002] 60 TCA #-#-# [003] 60 Docket Number 60 KSA #-# d 60 § #-# [004] 60 § 7B 60 IRCP 60 La. RS #:# [003] 60 Regulation SX 60 CFR #.# [003] 60 NJSA #A 60 Offerors Commercial Items 60 DTR #.#.# b 60 Act Pub. L. 60 LSA RS #:# [001] 60 Docket Nos. 60 ORS #A.# 60 KRS #A.# [002] 59 § § #-# [003] 59 NJRE 59 § #-# [001] 59 § #.#-# [002] 59 Non GAAP reconciliations 59 OCGA § #-#-# [007] 59 Aplt 59 SEC Rule #g# 59 1.a. 59 #.# subd [003] 59 SUPPLEMENTARY INFORMATION 59 LSA RS #:# [002] 59 USSG § #B#.# [002] 59 #-#.# [016] 59 CEQA Guidelines 59 Continuous Disclosure 59 USC § § #e 59 subsections b 59 Section #-#-# [007] 59 Subsections 59 § #.# [003] 59 Rule #f 59 OCGA § #-#-# [006] 59 RC #.# B [002] 59 Interpretive Guidance 59 FAR #.#-# [001] 59 P. #a 59 § #b [003] 59 RC #.# F 59 Celotex Corp. v. Catrett 59 END FOOTNOTE 59 Dkt 59 Reply Br 59 subparagraph B 59 NJSA 2A :# 59 #.#A [005] 59 Eur Urol 59 WAC #-#-# 58 NJSA #:#-# [002] 58 See TCA § 58 #-# CB 58 OS# § 58 Section #-#-# [004] 58 Internal Revenue Code § 58 KRS #.# [003] 58 Reproduced Record RR 58 § #A [003] 58 Evid.R. 58 IC § #-# 58 #.# subdivision [004] 58 FAR #.#-# [003] 58 section #.#.# 58 DOSAGE AND ADMINISTRATION 58 #b c 58 Federal Regulations CFR 58 See USSG 58 Evid 58 Rule #:#-# [002] 58 Offerors Commercial 58 Code § #.# [002] 58 ERISA § 58 FAR #.#-# [002] 58 § #.#-#.# 58 Gov't Code § 58 Fam. Code § 58 Complaint ¶ 58 RCW #A.#.# [002] 58 USC #a [002] 58 MB Docket 58 #.# subd [006] 58 SEC Rule #b 58 KRS #A.# [001] 58 #-#.# [014] 58 See INA § 58 § #A b 58 NJSA #:#-# [003] 58 NYCRR § 58 See USSG § #A#.# 58 #.#-# Offeror Representations 58 FAR Clause #.#-# 58 NJSA #:# [002] 58 Annexures 58 RSMo 58 § #B#.# [002] 58 #/#/EEC [002] 58 subsection b 58 NJSA #:# C 58 FINRA Rule 58 #B.# [002] 58 OCGA § #-#-# [001] 58 FAR #.#-# Instructions 58 DR #.#.#R 1 58 Judgments § 58 NRS #.# [003] 57 La.Code Civ.P. art 57 NIH Publication 57 ORS #.# [001] 57 Ala. R. Civ 57 App.R. 57 La.RS #:# [003] 57 § #.# Vernon 57 La.RS 57 CrR 57 [013] 57 FAR clauses 57 Section #-#-# [006] 57 Subpart E 57 OCGA § #-#-# [003] 57 vi vii 57 TCA § 57 Immtech scientists 57 HRS § #-# [002] 57 NJSA #:#-#.# [003] 57 TSCA Section 57 NYCRR #.# [003] 57 Restatement § 57 FR #-# [002] 57 Witkin Cal 57 § #-#-# c [001] 57 OCGA § 57 HRS § 57 RS #:# [002] 57 Rule #B 57 Section #AA [002] 57 subsection c 57 quoting Restatement Second 57 B.2 57 IC § 57 Gall v. 57 subsection d 57 Ohio Adm.Code #-#-# 57 Tex. R. Civ 57 #.#-# [016] 57 MSc Qualified Person 57 Code § #.#-# [001] 57 Appellant App 57 subparagraphs 57 § #A [002] 57 CICA Accounting Guideline 57 Accounting Standard AASB 57 Transcript Docket 57 website a.com 57 subsection f 57 section #-#-# [003] 57 #-#.# [026] 57 #.#-# Equal Opportunity 57 GL c 57 USCA § § 57 § § #-#-# [002] 57 Ferlay J et al 57 LBR #-# 57 Memory Legal Footnote 57 III.#.# 57 e xcept 56 Recent Accounting Pronouncements 56 § #.# subd [005] 56 Product Monograph 56 #.#.#R 56 certif 56 USC § § 56 Dkt. No. 56 Explanatory Note 56 ORS #.# [002] 56 § 7A 56 Regulations CFR 56 OSC Policy 56 Corporate Governance Statement 56 § § #-# [002] 56 Dkt. 56 Obes Res 56 Rule #h 56 Ord. 56 SCR #:#.# [001] 56 B.1 56 SEBI ICDR Regulations 56 § § 56 Rule #:#-# [001] 56 Wyo. Stat 56 § #a [001] 56 Proposed Rule 56 § #.# c 56 Filing Requirements 56 NJSA 56 Listing Manual 56 ll.# 56 Code § #-# [001] 56 Ariz. Sess 56 visit http:/www.nationwide.com 56 Exercising jurisdiction 56 DFAR 56 Offeror Representations 56 Appellant Brief 56 Counterparty Criteria 56 CrR #.# 56 Pure Biofuels ability 56 Corporate Governance Principles 56 PS § § 56 USC § #k 56 NDCC § 56 § #-#-# b [002] 56 Torts § 56 USC § 56 Continuous Disclosure Policy 56 Cal. Rules 56 Eur J Cancer 56 Civil Procedure Rule 56 #.#-# [001] 56 State ex rel 56 J Pediatr 56 WpHG mit dem Ziel 56 DFARS #.#-# 56 Contracts § 56 Graphics Legal Footnote 56 KRS #.# [001] 56 Reconciliation Tables 56 Preferential Issues 56 #.#-# [013] 56 USC § #j b 56 Short Explanation 56 OCGA § #-#-# [008] 56 O. Reg 56 FOIA Exemption 56 NRS #.# [002] 56 substitute LOCs 56 Civ. Code § 56 KSA #-# [002] 56 competitively procured pursuant 56 Wireless Legal Footnote 56 AS #.#.# 55 IEC EN #-#-# 55 Offerors Commercial applies 55 #CFR Part 55 subpart 55 Am J Epidemiol 55 La. RS #:# [002] 55 i #.# subds 55 Certifications Commercial Items 55 § #.# d 55 TCA § #-#-# [001] 55 Original Bidder Statement 55 CS § 55 FIFRA 55 Wis. Stat 55 #.# RSMo 55 Appendix 3B Page 55 Arkansas Code Annotated 55 Arizona Revised Statutes 55 Processor Legal Footnote 55 USSG § 55 Exh 55 La. RS #:#.# 55 Code Civ 55 vphl Norwegian Securities 55 directive #/#/EC [001] 55 § #b [001] 55 FAR #.#-# Offeror Representations 55 Competitive Impact Statement 55 Opp'n 55 MCL #.# [001] 55 SDNY Mar. 55 § #G#.# b 55 Elias Zacarias 55 EFFECTIVE DATE 55 suppl 55 #-#-#.# [002] 55 #K#.# 55 ILCS #/#-# [002] 55 J Natl Cancer Inst 55 CVM Instruction 55 subsequent amendments thereto 55 General Statutes § 55 wv ` 55 AS NZS #.# 55 Immtech clinical trials 55 RSA #:# [001] 55 ErP 55 CODE § 55 A.2 55 Doc. 55 CPLR § 55 Rule #e 55 Professional Conduct Rule 55 www.epeat.net 55 Resp 55 Appendix B 55 reh'g 55 f ailure 55 #:#.# [016] 55 INA § 55 :# [002] 55 NYSE Arca Equities 55 Vertical Restraints 55 Tex. Fam 55 Doc. # 55 #.#.#.# [011] 55 FR # [001] 55 HSW Act 55 #:# [013] 55 Ind. Code § 55 doc. 55 RC #.# [002] 55 ii iii 55 DR #.#.# 55 GRIH Web site 55 See OCGA § 55 #:#-# [002] 55 Arch Dermatol 55 #.#-# Instructions 55 DFARS 55 Docket ID 55 Wende supra 55 Rule #-#.# 55 CFR Part 55 Takeovers Regulations 55 Suppl 55 Evid. Code § § 55 NAICS code # 55 EPA HQ OAR 55 Pl. 55 Ann Oncol 55 v. Olano 55 Nat Med 55 Rodenticide Act FIFRA 55 IRTPA 55 Geov Parrish archives 55 Pl. s 55 :7 55 #a subdivision 55 CALCRIM Nos. 54 iii iv 54 # et seq 54 CRCP 54 #.#-# Evaluation Commercial 54 Tenn. R. Evid 54 #.# subds [001] 54 NYCRR 54 Ohio Adm.Code 54 n.1 54 § #a [003] 54 § § #-# [001] 54 Suppl. 54 inspectional observations 54 Rule #g# 2 54 Unfunded Mandates Reform Act 54 Supplementary Explanatory Memorandum 54 § #C#.# 54 ps :# 54 Customs Tariff Act 54 Thromb Haemost 54 #/#/EC [002] 54 IV.#.# 54 Oral Arg 54 Rent Stabilization Code 54 Doc. No. 54 Compl. ¶ 54 Certifications Commercial 54 B.3 54 § #.#-# [006] 54 SR ISE 54 § #B 54 LSA RS 54 Resp't 54 IEC #-#-# [003] 54 Civil Code § 54 Disclosure Requirement 54 et seq 54 #a #a [003] 54 #a #a [002] 54 s.# [001] 54 Minn. R. Evid 54 #A.# [002] 54 ARS § #-# [001] 54 Revised Guidelines 54 CFR Pt 54 See USSG § #D#.# 54 section #-#-# [002] 54 Tr. 54 :5 54 Code § § 54 J Affect Disord 54 b LiquidStockReport.com 54 Nasdaq Listing Rule 54 subsection h 54 La.Civ.Code art 54 FSP AUG AIR 54 IIROC Dealer Member 54 Free Full Text 54 Listing Rule #.#.# [005] 54 Segregated Facilities 54 Docket Entry 54 FCC Rcd 54 WC Docket No. 54 IC § § 54 Id. ¶ 54 ACN ABN 54 Subpart III 54 v. Cronic 54 Ann Emerg Med 54 Reply Brief 54 Schizophr Res 54 SEBI Guidelines 54 CD# [004] 54 Jian Hui Shao 54 Docket No. 54 People v. Waidla 54 8 CFR § 54 #.#-# Contract Terms [002] 54 Slip Op 54 SCR #:#.# [002] 54 Complaint ¶ ¶ 54 Coalcorp Provides Updated 54 Full Prescribing Information 54 J Clin Psychiatry 54 #-#.# [017] 54 n.4 54 HERE LIVE 54 OCGA 54 Listing Rule #.#.# [003] 54 Def. s 54 Appellants Br 54 NJSA #A #A 54 Mutual Funds Regulations 54 affd 54 § #-# [003] 54 RCW #.#.# [002] 54 thereof Controls 54 DGAP PVR Publication 54 Variable Interest Entities FIN 54 s#A [002] 53 Restatement Second 53 dkt 53 R.# [001] 53 Administrative Code § 53 Prescribing Information 53 Bell Atl 53 pari materia 53 Tex. R. 53 DOT OST 53 Stimmrechtsmitteilung pursuant 53 § #.#-# [003] 53 P# [002] 53 Subsidiary Arrangements 53 Code § #-#.# 53 NRS #.# [001] 53 constitutes discloseable transaction 53 ARS § #-# [002] 53 Ark. R. Crim 53 Florida Statute #.# [002] 53 reh'g denied 53 Product Characteristics 53 supra § 53 Pharmacopoeia USP 53 inaccordance 53 securityholder approvals 53 Defs. 53 #j [001] 53 LEXIS # [001] 53 visit www.caesarswindsor.com 53 Code § #-# [003] 53 Rosenkrantz supra 53 #a [004] 53 www.mprpd.org 53 Supplementary Material 53 FDAAA 53 ^ sup -1 53 CPLR 53 p rior 53 Regulated Activities 53 NRS #A.# 53 Nonprescription Drug Consumer 53 Segregated Facilities Feb 53 dated #.#.# [002] 53 Civ.R. 53 pharmacotherapeutics 53 Hedging Relationships AcG 53 § #-#-# g 53 Subsection d 53 Gen. Stat 53 Arizona Revised Statute 53 Guidance Document 53 Order Granting 53 #S #S [001] 53 subparagraph b 53 Accounting Guideline 53 :4 53 annexed hereto 53 COPPA Rule 53 Interrogatory No. 53 Code § #-# [002] 53 #.#-# Affirmative Action 53 Position EITF #-#-# 53 Kidney Int 53 SUMMARY TABLE 53 Notice #-# [001] 53 Federal eRulemaking Portal 53 Supplementary Data 53 n.8 53 Bell v. Wolfish 53 Code Sections 53 sec. 53 #/#/CE 53 categories Internal Cleansers 53 FMIA 53 #.#-# Convict Labor 53 Administrative Procedure 53 KSA #-# b 53 C.1 53 Agreement constitutes discloseable 53 RESTATEMENT SECOND OF 53 Tennessee Code Annotated 53 XIV § 53 Pricing Supplement 53 ADDITIONAL INFORMATION .vectorless 53 Chapter 6D 53 IEC EN 53 Italian Legislative Decree 53 NCAA Bylaw #.#.# 53 DCID 6 53 Circular dated 53 ASX Listing 53 Br J Clin Pharmacol 53 HEI Quarterly Report 53 substitute SBPA 53 KAR #:# 53 § #c subd 53 Disclosure Document 53 Largo website www.largoresources.com 53 Hawaii Revised Statutes 53 Deltafina 53 J Clin Endocrinol Metab 53 NUREG 53 USC § #o 53 #/#/EEC [001] 53 § #-#-# c [002] 53 http:/www.mpegla.com 53 Sentencing Tr 53 Interpretative Communication 53 perso MORE 53 Ann Rheum Dis 53 SEBI DIP Guidelines 53 Stmt 53 RCW #.#.# [001] 53 Ann Intern Med 53 Règlement 53 Subpart H 53 Trial Tr 53 Obstet Gynecol 53 Multilateral Instrument 53 Regulatory Flexibility Act 53 EMBO J. 53 NYCRR #.# d 53 USDA FSIS 53 Dkt. # 53 FR #-# [001] 53 Mol Biol 53 Ala. Code § 53 AFI #-# 53 Listing Requirement 53 Solicitation Statement 53 MGL Chapter 53 R. Civ 53 § #G#.# 53 #/#/EC [001] 53 THE OFFER .oriental spices 53 b Disclosure SmallcapInsights.com 53 SPECIAL BUSINESS 52 accordance LR #.#.#R 52 5TH CIR 52 boxed WARNING 52 FAR Subpart 52 SEBI SAST Regulations 52 Plaintiff Complaint 52 #A.# [001] 52 II.#.# 52 Exs 52 ADAAG 52 § #L#.# b 52 FASEB J. 52 #-#-# COPYRIGHT 52 Listing Rule #.#A 52 Psychosom Med 52 Clin Psychol Rev 52 WpUG 52 C.# 52 Schizophr Bull 52 ILCS #/#-# [001] 52 '# patent ll.# 52 S1 S# [001] 52 § #e 52 § #:# [002] 52 NOTIFICATION OF MAJOR INTERESTS 52 Int Clin Psychopharmacol 52 Capital Disclosures 52 EIA Notification 52 subparagraph 52 MEMO/#/# [002] 52 ADOPTION OF THE 52 Subchapter 52 FS #.# [001] 52 RS #:# [001] 52 Annuity Transactions Model 52 Amending Directive 52 internal citations omitted 52 #.#.#.#.#.# 52 certi 52 internal citation omitted 52 Eur Respir J 52 w illus 52 Rule 2a 52 hereof shall 52 Judicature Act 52 directive #/#/EC [002] 52 Stats. 52 Listing Rule #.#.# [001] 52 ref'd 52 #.#-# #.#-# #.#-# #.#-# 52 Offer Document dated 52 Ordinance Cap. 52 PARAGRAPH 52 Appellant Br 52 #.# subdivision [003] 52 J Clin Invest 52 Acquisition Regulation FAR 52 Undisputed Facts 52 n.# [001] 52 Regulatory Policies 52 st Cir 52 Rules #b# 52 # endif 52 J Clin Oncol 52 relation thereto 52 NGER Act 52 CALCRIM 52 Raw #/#/# Punjab 52 p.# [001] 52 Bombay Tenancy 52 Mol Med 52 J Psychiatr Res 52 Pen. Code § #.# [001] 52 n.3 52 DOI #.#/S#-# 52 J Rheumatol 52 Arch Intern Med 52 ORC #.# 52 Slip op 52 Acta Psychiatr Scand 52 adjuvant systemic 52 Gov.Bar R. V 52 http:/www.platts.com/Products.aspx?xmlFile=oilgraLaurene Powell 52 RCr 52 MSRB Rule G 52 ASME Boiler 52 Minimum Stockholders Equity 52 DJ DGAP PVR Publication 52 KRS #.# [002] 52 MHPAEA 52 Section #A.# 52 NJSA 2C :# 2a 52 EU Directive #/#/EC 52 ATEX Directive 52 #.# subdivision [002] 52 J Clin Psychopharmacol 52 Determining Whether 52 .cagy veteran 52 Delisting Regulations 52 INTRODUCTION I. 52 Metab Disord 52 Proposed Regulations 52 #-# #-# [013] 52 Section #b 52 TVID 52 #A#.# 52 WEEE #/#/EC 52 La.RS #:# [002] 52 Subtitle B 52 § 52 Psychiatry Res 52 Pub. 52 Biol Psychiatry 52 promulgated pursuant 52 Nevada Revised Statutes 52 Supplementary Prospectus 52 iii 52 Business Spectator glossary 52 SLHCs 52 para. 52 Am J Cardiol 52 Rule #a [002] 52 ALS Analytical 52 Osteoporos Int 52 .W. McNichols 52 Arch Neurol 52 Proposing Release 52 la Borsa CONSOB 52 Appendix 5B 52 J Child Adolesc 52 Appx 52 SEBI Delisting 52 Tex. R. Evid 52 FINANCIAL STATEMENTS FOR 52 s ection 52 Partial Revocation 52 Legislative Decree 52 L.#/# 52 I# I# [002] 52 Clin Trials 52 Curr Opin 52 Prudential Ins 52 RCW #A.#.# [001] 52 mem. op 52 Genome Res 52 Int J Epidemiol 52 Quinton Hennigh Ph.D. P.Geo 52 Am J Clin 52 § 8C 1 52 Premarket Approval 52 USSG § #K#.# b 52 Nat Genet 52 art. 52 FAR Subpart #.# 52 applies prospectively 52 Approvable 52 Supplemental Data 52 Crit Care 52 Compl. ¶ ¶ 51 ABN AMRO Warrants 51 Section #C [001] 51 Permitted Holders 51 COLLIER ON 51 SEBI Substantial Acquisition 51 op. 51 #-#-#.# [004] 51 PURSUANT TO 51 Simplified Acquisition 51 Proposed Arrangement 51 www.parl.gc.ca 51 Section #.# [002] 51 Allstate Ins 51 M Models Excluded 51 Eur J Pharmacol 51 Art. 51 vii viii 51 lender consents 51 BOFIA 51 Probate Code 51 NSF ANSI 51 Nasdaq Listing Rules 51 subsection 51 PHILIP MORRIS INTERNATIONAL INC. 51 Authorisations 51 MGL c 51 2d Dept 51 CRS #-#-# [001] 51 Listing Application 51 s.# [002] 51 Boxed WARNING 51 § 8C 51 u nless 51 entitled Caution Regarding 51 Uniform Arbitration 51 USSG § #D#.# 51 Minn. Stat 51 Ala. R. Crim 51 Homeopathic Pharmacopoeia 51 Subpart 51 http:/www.grassrootinstitute.org/ 51 DIN ISO 51 India Substantial Acquisition 51 De Minimis 51 doi #.#/S#-# 51 http:/www.wallstreetgrand.com/disclosure.html 51 People v. Gardeley 51 scienter requirement 51 Crim.R. 51 Advisers Act 51 Nationwide Mut 51 Oregon Revised Statutes 51 RH DONNELLEY CORPORATION 51 generis 51 Pract 51 id. § 51 Fla. R. Crim 51 Proposed Revisions 51 Psychol Med 51 Docket # 51 Note Indenture 51 Code § #.# [004] 51 DTR #.#.# 51 J Am Soc 51 Kentucky Revised Statutes 51 DR #-# 51 meaning ascribed thereto 51 Section #-#-# [001] 51 jurisdictional prerequisite 51 Accelerated Approval 51 Mol Psychiatry 51 Arch Pediatr Adolesc Med 51 Implementing Recommendations 51 DIN EN # 51 #.#-# [033]